Gene Therapy: Page
-
Gilead reaches deal for Yescarta coverage in England
For now, the CAR-T therapy will be provided through NHS' Cancer Drugs Fund, after a government agency judged it too pricey for routine coverage.
By Ned Pagliarulo • Oct. 5, 2018 -
Sarepta gene therapy for DMD takes another step forward
Updated results, including data from a fourth boy with Duchenne muscular dystrophy, help to firm up the prospects for the biotech's gene therapy.
By Ned Pagliarulo • Oct. 4, 2018 -
Explore the Trendline➔
Getty Images
TrendlineGene Therapy
Rapid scientific advances have put the gene therapy field at the forefront of biomedical research. But, as recent setbacks have shown, researchers and drugmakers still face major challenges.
By BioPharma Dive staff
To find more content, use the "Topics" in the menu above.